Fujirebio Europe News and Activities

Fujirebio Europe is owned by HU Group Holdings.

HU Group Holdings is one of the...

• TOB Iconic 10,000;
• Topix.

HU Group Holdings is a company listed under the stock ticker 4544 (JP).

HU Group Holdings has a direct presence in 4 countries.

HU Group Holdings has 5 subsidiaries including Fujirebio, Fujirebio Diagnostics and Fujirebio Diagnostics Europe.

They are in:

• Biotechnology33%
• Medical Equipment33%
• Other33%

View the org chart displaying its 14 main executives

Most searched biographies at Fujirebio Europe

• Christiaan De Wilde, Chief Executive Officer
• Kris D'Hoey, Chief Financial Officer
• Laura De Beule, Quality Control Officer

Popular executive movements at HU Group Holdings

• Shigekazu Takeuchi, Representative Executive Officer, Vice President and Director, is retiring  (posted on January 14 2026).
• Goki Ishikawa, who was Chief Executive Office, In Vitro Diagnostics, is promoted to President and Chief Executive Officer  (posted on January 14 2026).

Create your alert
to follow the executive moves at Fujirebio Europe.

HU Group Holdings has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Fujirebio Europe

Social media about Fujirebio Europe

• Fujirebio Europe on Wikipedia, Google News & Yahoo Finance
• Fujirebio Europe on LinkedIn, X (Twitter) & YouTube